1A01260

(16a)-16,17,21-Trihydroxypregna-1,4,9(11)-triene-3,20-dione

Pharmaceutical Analytical Impurity (PAI)

• 別名: (16α)-16,17,21-Trihydroxypregna-1,4,9(11)-triene-3,20-dione, (8S,10S,13S,14S,16R,17S)-16,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,10,12,13,14,15,16,17-decahydro-3H-cyclopenta[a]phenanthren-3-one, 16α,17,21-Trihydroxy-pregna-1,4,9(11)-triene-3,20-dione
• 実験式（ヒル表記法）: C₂₁H₂₆O₅
• CAS番号: 39672-76-9
• 分子量: 358.43
• UNSPSCコード: 41116107
• NACRES: NA.24

特性

• グレード: pharmaceutical analytical impurity (PAI)
• 認証: USP
• APIファミリー: budesonide
• メーカー／製品名: USP
• アプリケーション: pharmaceutical
• フォーマット: neat
• 保管温度: 2-8°C

詳細

詳細

(16α)-16,17,21-Trihydroxypregna-1,4,9(11)-triene-3,20-dione is a USP Pharmaceutical Analytical Impurity (PAI).

USP PAI are a product line of impurities suitable for research and analytical purposes, which help to ensure the quality and safety of medicines.

Associated Drug Substance: Budesonide

Therapeutic Area: Steroids

For more information about this PAI, visit here.

アプリケーション

(16α)-16,17,21-Trihydroxypregna-1,4,9(11)-triene-3,20-dione (USP PAI) is intended for use in analytical testing to detect, identify, and measure pharmaceutical impurities.

特徴および利点

USP PAI advance your early analytical R&D and process development. PAI can be used in the following applications:

1. Conduct analytical tests during early formulation feasibility studies.
2. Determine degradation impurities produced during stress studies.
3. Develop, validate, and transfer analytical methods.
4. Perform spiking studies during process R&D to demonstrate depletion upon recrystallization.
5. Record retention times and/or spectra
6. Determine relative response factors.
7. Identify unknown impurities that formed during ICH stability conditions.
8. Identify impurities that are present in the Reference Listed Drug
9. Test for and profile impurities not listed in drug substance and drug product monographs.

アナリシスノート

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  

その他情報

Sales restrictions may apply.

安全性情報

• ピクトグラム: GHS08
• シグナルワード: Warning
• 危険有害性情報: H361d
• 注意書き: P201 - P202 - P280 - P308 + P313 - P405 - P501
• 危険有害性の分類: Repr. 2
• 保管分類コード: 11 - Combustible Solids
• WGK: WGK 3
• 引火点(°F): Not applicable
• 引火点(℃): Not applicable